A citation-based method for searching scientific literature

Motoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi. Am J Respir Crit Care Med 2014
Times Cited: 224







List of co-cited articles
596 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
64

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
46

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
42

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
539
42

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
428
28

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
27

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
26

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
24

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
731
22

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
17

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
876
16

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
598
16

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.
Harold R Collard, Luca Richeldi, Dong Soon Kim, Hiroyuki Taniguchi, Inga Tschoepe, Maurizio Luisetti, Jesse Roman, Gregory Tino, Rozsa Schlenker-Herceg, Christoph Hallmann,[...]. Eur Respir J 2017
71
21

Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
608
14

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
Harold R Collard, Eric Yow, Luca Richeldi, Kevin J Anstrom, Craig Glazer. Respir Res 2013
119
14

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Evans R Fernández Pérez, Craig E Daniels, Darrell R Schroeder, Jennifer St Sauver, Thomas E Hartman, Brian J Bartholmai, Eunhee S Yi, Jay H Ryu. Chest 2010
271
14

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
641
12

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
I-Nae Park, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby. Chest 2007
211
12

Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kensuke Kataoka, Hiroyuki Taniguchi, Yasuhiro Kondoh, Osamu Nishiyama, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Koji Sakamoto, Masahiko Ando. Chest 2015
77
15

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
12

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Luca Richeldi, Vincent Cottin, Roland M du Bois, Moisés Selman, Toshio Kimura, Zelie Bailes, Rozsa Schlenker-Herceg, Susanne Stowasser, Kevin K Brown. Respir Med 2016
210
10

Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.
Y Kondoh, H Taniguchi, T Katsuta, K Kataoka, T Kimura, O Nishiyama, K Sakamoto, T Johkoh, M Nishimura, K Ono,[...]. Sarcoidosis Vasc Diffuse Lung Dis 2010
114
10


Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.
Kerri A Johannson, Eric Vittinghoff, Kiyoung Lee, John R Balmes, Wonjun Ji, Gilaad G Kaplan, Dong Soon Kim, Harold R Collard. Eur Respir J 2014
121
10

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
451
10

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
Ganesh Raghu, Shih-Yin Chen, Wei-Shi Yeh, Brad Maroni, Qian Li, Yuan-Chi Lee, Harold R Collard. Lancet Respir Med 2014
318
10

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
430
10

The rising incidence of idiopathic pulmonary fibrosis in the U.K.
V Navaratnam, K M Fleming, J West, C J P Smith, R G Jenkins, A Fogarty, R B Hubbard. Thorax 2011
299
9

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
799
9

Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Ganesh Raghu, Shih-Yin Chen, Qiang Hou, Wei-Shi Yeh, Harold R Collard. Eur Respir J 2016
134
9

Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials.
Arata Azuma, Hiroyuki Taniguchi, Yoshikazu Inoue, Yasuhiro Kondoh, Takashi Ogura, Sakae Homma, Tsuyoshi Fujimoto, Wataru Sakamoto, Yukihiko Sugiyama, Toshihiro Nukiwa. Respirology 2017
26
30

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
348
8

Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Sakae Homma, Masashi Bando, Arata Azuma, Susumu Sakamoto, Keishi Sugino, Yoshiki Ishii, Shinyu Izumi, Naohiko Inase, Yoshikazu Inoue, Masahito Ebina,[...]. Respir Investig 2018
31
25

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, Moritaka Suga, Shosaku Abe, Koichiro Nakata, Yoshio Taguchi, Sonoko Nagai, Harumi Itoh, Motoharu Ohi,[...]. Am J Respir Crit Care Med 2005
621
8

Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis.
Kyeongman Jeon, Man Pyo Chung, Kyung Soo Lee, Myung Jin Chung, Joungho Han, Won-Jung Koh, Gee Young Suh, Hojoong Kim, O Jung Kwon. Respir Med 2006
43
18

Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Robert B Hopkins, Natasha Burke, Charlene Fell, Genevieve Dion, Martin Kolb. Eur Respir J 2016
71
11

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
8

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
Brett Ley, Jeffrey Swigris, Bann-Mo Day, John L Stauffer, Karina Raimundo, Willis Chou, Harold R Collard. Am J Respir Crit Care Med 2017
85
9

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Ulrich Costabel, Yoshikazu Inoue, Luca Richeldi, Harold R Collard, Inga Tschoepe, Susanne Stowasser, Arata Azuma. Am J Respir Crit Care Med 2016
151
7



Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Nobuoki Kohno, Francesco Bonella, Josune Guzman, Ulrich Costabel. Respir Med 2014
100
7


Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
343
7

Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Kenji Tsushima, Koichi Yamaguchi, Yuta Kono, Toshiki Yokoyama, Keishi Kubo, Takuma Matsumura, Yasunori Ichimura, Mitsuhiro Abe, Jiro Terada, Koichiro Tatsumi. Pulm Pharmacol Ther 2014
46
15

Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Kenta Furuya, Susumu Sakamoto, Hiroshige Shimizu, Muneyuki Sekiya, Arisa Kinoshita, Takuma Isshiki, Keishi Sugino, Keiko Matsumoto, Sakae Homma. Respir Med 2017
22
31

Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.
Takuma Isshiki, Susumu Sakamoto, Arisa Kinoshita, Keishi Sugino, Atsuko Kurosaki, Sakae Homma. Respiration 2015
47
14

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
Susumu Sakamoto, Hiroshige Shimizu, Takuma Isshiki, Keishi Sugino, Atsuko Kurosaki, Sakae Homma. Respir Investig 2018
19
36

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study.
Marco Mura, Maria A Porretta, Elena Bargagli, Gianluigi Sergiacomi, Maurizio Zompatori, Nicola Sverzellati, Amedeo Taglieri, Fabrizio Mezzasalma, Paola Rottoli, Cesare Saltini,[...]. Eur Respir J 2012
126
7

Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.
Jonas Christian Schupp, Harald Binder, Benedikt Jäger, Giuseppe Cillis, Gernot Zissel, Joachim Müller-Quernheim, Antje Prasse. PLoS One 2015
89
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.